Pharmacokinetic evaluation of anticonvulsants prior to efficacy testing exemplified by carbamazepine in epileptic monkey model.
D000284:Administration, Oral; D000818:Animals; D002220:Carbamazepine / Q000008:administration & dosage* / Q000378:metabolism; D003692:Delayed-Action Preparations; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004827:Epilepsy / Q000188:drug therapy*; D006207:Half-Life; D000882:Haplorhini; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008251:Macaca; D012996:Solutions; D013607:Tablets
D003692:Delayed-Action Preparations; D012996:Solutions; D013607:Tablets; D002220:Carbamazepine